Frontiers in Medicine (Aug 2021)
Mobile Health Technology for the Personalized Therapy of Hemophilia
- Noemi Dirzu,
- Ionut Hotea,
- Ionut Hotea,
- Ionut Hotea,
- Ciprian Jitaru,
- Ciprian Jitaru,
- Melen Brinza,
- Melen Brinza,
- Laura Urian,
- Laura Urian,
- Mareike-Catrina Peters,
- Krisztina Gal,
- Louis Popescu,
- Cristina Blag,
- Cristina Blag,
- Mirela Marian,
- Eva Pal,
- Marilena Stanescu,
- Diana Cenariu,
- Cristina Tarniceriu,
- Cristina Tarniceriu,
- Margit Serban,
- Margit Serban,
- Delia Dima,
- Daniel Coriu,
- Daniel Coriu,
- Ciprian Tomuleasa,
- Ciprian Tomuleasa,
- Ciprian Tomuleasa
Affiliations
- Noemi Dirzu
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Ionut Hotea
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Ionut Hotea
- Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Ionut Hotea
- Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania
- Ciprian Jitaru
- Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Ciprian Jitaru
- Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania
- Melen Brinza
- Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania
- Melen Brinza
- Department of Hematology, Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania
- Laura Urian
- Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Laura Urian
- Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania
- Mareike-Catrina Peters
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Krisztina Gal
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Louis Popescu
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Cristina Blag
- Department of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Cristina Blag
- Department of Hematology, Emergency Clinical Children's Hospital, Cluj Napoca, Romania
- Mirela Marian
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Eva Pal
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Marilena Stanescu
- Takeda Pharmaceutical Company, Tokyo, Japan
- Diana Cenariu
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Cristina Tarniceriu
- Department of Anatomy, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
- Cristina Tarniceriu
- 0Department of Hematology, St. Spiridon County Clinical Emergency Hospital, Iasi, Romania
- Margit Serban
- 1Department of Hematology, Victor Babes University of Medicine and Pharmacy Timisoara, Timisoara, Romania
- Margit Serban
- 2European Haemophilia Treatment Center, Timisoara, Romania
- Delia Dima
- Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Daniel Coriu
- Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania
- Daniel Coriu
- Department of Hematology, Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania
- Ciprian Tomuleasa
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Ciprian Tomuleasa
- Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania
- Ciprian Tomuleasa
- Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania
- DOI
- https://doi.org/10.3389/fmed.2021.711973
- Journal volume & issue
-
Vol. 8
Abstract
The management of patients with hemophilia has evolved significantly since the first treatment attempts were made in the late 1930s. Since then, each new step in the treatment of patients with hemophilia has brought important advancements, as well as its unique set of challenges. Today, a patient-centered, individualized comprehensive approach is the new paradigm, moving away from the traditional “one size-fits-all” approach, to provide the best possible care for each patient with a bleeding disorder. As part of this complex task, mobile health applications might have the capacity to play an important role in reaching that goal. However, the use of new electronic technologies as part of a comprehensive treatment approach for patients with hemophilia simultaneously presents a new set of challenges that needs consideration. In the first section, currently available treatment of hemophilia patients will be revised, while in the second part the role of IT software in the treatment monitoring of hemophilia patients will be discussed.
Keywords